EGFR and esophageal squamous cell carcinoma: Despite with different detection methods for EGFR copy number, we showed that EGFR CNG, as detected by copy number assays, was proved to be the predictor for afatinib efficacy, which further verified the role of EGFR as a potential target in ESCC and was consistent with what we have found in gastric cancer [21].